Lumibird: NINE-MONTH REVENUES OF €125M (+11%)
24 Oktober 2022 - 5:45PM
Lumibird: NINE-MONTH REVENUES OF €125M (+11%)
Lannion, October 24, 2022 – 5:45pm
NINE-MONTH REVENUES OF €125M (+11%)
- Sustained growth maintained
for both divisions
- Strong level of business
expected for the fourth quarter
The LUMIBIRD Group, the European leader
for laser technologies, once again recorded double-digit growth in
the third quarter, with revenues up 10% to €40.9m, and €124.9m for
the first nine months of the year (+11%). As in previous years, the
Group is forecasting a stronger level of business in the fourth
quarter.
Consolidated revenues
(unaudited)
Revenues (€m) |
2022 |
2021 |
Reported change |
Change at constant exchange rates |
First quarter |
38.0 |
33.8 |
+12% |
+11% |
Second quarter |
46.0 |
41.7 |
+10% |
+7% |
Third quarter |
40.9 |
37.2 |
+10% |
+7% |
Nine months |
124.9 |
112.6 |
+11% |
+8% |
of which |
|
|
|
|
Photonics |
58.2 |
52.7 |
+11% |
+8% |
Medical |
66.7 |
60.0 |
+11% |
+9% |
The LUMIBIRD Group’s consolidated revenues came
to €124.9m at September 30, 2022, up 8% like-for-like and at
constant exchange rates. Due to the strong increase in the dollar
over the period, revenue growth based on reported data rose to 11%
for the first nine months of the year.
Over nine months, the Photonics and Medical
divisions both progressed at the same rate, with the third quarter
seeing slightly quicker business growth for the Medical division
(+11% to €21.3m) than Photonics (+9% to €19.6m).
The increase in revenues for the
Photonics division is linked to the third-quarter
growth (+8% to €9.0m) for the Industrial and Scientific business
(+4% over nine months to €26.3m), while the Lidar business was
stable in the third quarter (+2% to €5.4m) following a very strong
second quarter (+29% over nine months to €16.4m), and the third
quarter’s growth (+18% to €5.2m) for the Defense / Space business
(+6% over nine months to €15.4m). The integration of the Defense
Rangefinder business (previously Saab) into Lumibird Photonics
Sweden contributed €0.9m to revenues in the third quarter, with
€1.2m since it was integrated at the end of May 2022.
The Defense / Space business (with the phasing
of contracts and the integration of Sweden) and the Lidar business
will strongly support the Photonics division’s robust development
in the fourth quarter of 2022.
The Medical division is
continuing to benefit from an acceleration in its sales across all
the geographies. The strengthening of the sales and marketing
teams, the extension of the product range to include buoyant
markets, thanks in particular to the launch of CSTIM for dry eye
treatment, and the achievement of several certifications and
registrations support this positive trend.
As each year at the same period, based on the
order book and delivery schedule, fourth-quarter revenues are
expected to be significantly higher than the previous three
quarters. (€49.8m of revenues for the fourth quarter of 2021
excluding Lumibird Photonics Sweden).
The Group is putting everything in place to
achieve its 2022 revenue target in line with the consensus, against
a backdrop of difficulties with supply chains, sourcing and rising
costs (strong inflation, particularly for electronics).
Next date:
2022 FY revenues on January 23, 2023 (after
close of trading)
LUMIBIRD is one of the world's leading
specialists in lasers. With 50 years of experience and a mastering
of solid state laser, laser diodes and fiber laser technologies,
the Group designs, manufactures and markets high performance lasers
for scientific (laboratories and universities), industrial
(manufacturing, defense, Lidar sensors) and medical (ophthalmology,
ultrasound diagnostic) markets.
Born from the combination of Keopsys Group with
Quantel in October 2017, LUMIBIRD has more than 940 employees and
over €162 million of consolidated revenues in 2021 and is
present in Europe, America and Asia.
LUMIBIRD shares are listed on the
Euronext Paris B Compartment. FR0000038242 –
LBIRD www.lumibird.comSince
2022, LUMIBIRD is part of Euronext Tech
Leaders
Contacts
LUMIBIRDMarc Le FlohicChairman and CEOTel. +33(0) 1 69 29 17
00info@lumibird.com |
LUMIBIRDAude Nomblot-GourhandSecretary General – CFOTel. +33(0) 1
69 29 17 00info@lumibird.com |
CalyptusMathieu CalleuxInvestors RelationsTel. +33(0) 1 53 65 37
91lumibird@calyptus.net |
- 221024LumibirdCAT3_2022_EN
Lumibird (EU:LBIRD)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Lumibird (EU:LBIRD)
Historical Stock Chart
Von Apr 2023 bis Apr 2024